» Articles » PMID: 36070685

Weight Loss, Type 2 Diabetes, and Nutrition in 355 Patients with Obesity Undergoing Sleeve Gastrectomy with Transit Bipartition: Two-Year Outcomes

Overview
Journal Obes Facts
Publisher Karger
Specialty Endocrinology
Date 2022 Sep 7
PMID 36070685
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study examined whether 355 obese patients with type 2 diabetes (T2D) of varying duration and severity experienced equivalent weight loss and T2D remission following a newer sleeve gastrectomy (SG) procedure - SG with transit bipartition (SG-TB).

Methods: Primary outcomes were changes in body mass index (BMI), total weight loss (TWL), excess BMI loss (EBMIL), A1C, and diabetes medication use through 24 months.

Results: Between December 2015 and December 2019, 399 patients who underwent SG-TB reached the 2-year time point. Follow-up was possible in 355 patients (89.0%): 206 females (58.0%), mean age 51.5 years (24.0-73.0), BMI 34.0 kg/m2 (28.0-50.5), and T2D duration 12.0 years (4.0-37.0). At 2 years, total sample respective mean TWL and EBMIL were 20.2 ± 6.1% (95% CI: 19.5, 20.8) and 87.7 ± 35.2% (84.1, 91.4) corresponding to mean BMI change of 7.0 ± 2.7 kg/m2 (6.7, 7.3) (p < 0.001). T2D duration and severity subgroups experienced comparable BMI and A1C change from baseline (p < 0.001); 281 (79.2%) maintained complete remission. ANOVA showed significant mean increases in vitamin D, calcium, and albumin: overall complication rate, 10.2%; no mortality.

Discussion/conclusion: In 355 patients with obesity who underwent SG-TB, excellent weight loss, T2D, and nutritional outcomes were seen at 2-year follow-up regardless of preoperative T2D duration and severity.

Citing Articles

Novel Surgical Interventions for the Treatment of Obesity.

Perrotta G, Bocchinfuso S, Jawhar N, Gajjar A, Betancourt R, Portela R J Clin Med. 2024; 13(17).

PMID: 39274492 PMC: 11396194. DOI: 10.3390/jcm13175279.


Clarifying the Heterogeneity in Response to Vitamin D in the Development, Prevention, and Treatment of Type 2 Diabetes Mellitus: A Narrative Review.

Hands J, Corr P, Frame L Int J Environ Res Public Health. 2023; 20(12).

PMID: 37372772 PMC: 10298297. DOI: 10.3390/ijerph20126187.

References
1.
Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A . Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311(22):2297-304. DOI: 10.1001/jama.2014.5988. View

2.
Santoro S, Malzoni C, Velhote M, Milleo F, Santo M, Klajner S . Digestive Adaptation with Intestinal Reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006; 16(10):1371-9. DOI: 10.1381/096089206778663841. View

3.
Karaca F . Effects of Sleeve Gastrectomy with Transit Bipartition on Glycemic Variables, Lipid Profile, Liver Enzymes, and Nutritional Status in Type 2 Diabetes Mellitus Patients. Obes Surg. 2020; 30(4):1437-1445. DOI: 10.1007/s11695-019-04326-0. View

4.
Guraya S, Strate T . Surgical outcome of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass for resolution of type 2 diabetes mellitus: A systematic review and meta-analysis. World J Gastroenterol. 2020; 26(8):865-876. PMC: 7052530. DOI: 10.3748/wjg.v26.i8.865. View

5.
Rubino F, Nathan D, Eckel R, Schauer P, Alberti K, Zimmet P . Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016; 39(6):861-77. DOI: 10.2337/dc16-0236. View